Anti-tumour-necrosis-factor-alpha agents and the heart: beyond left ventricular systolic dysfunction?

被引：0
|
作者：
Vassiliou, Vassilis [1 ]
Ntatsaki, Eleana [2 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Rheumatol, Norwich, Norfolk, England
来源：
NEW ZEALAND MEDICAL JOURNAL | 2011年 / 124卷 / 1343期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 78
页数：3
相关论文
共 50 条
  • [31] Tumor Necrosis Factor-α Mediates Inflammation-induced Early-Stage Left Ventricular Systolic Dysfunction
    Manilall, Ashmeetha
    Mokotedi, Lebogang
    Gunter, Sule
    Le Roux, Regina
    Fourie, Serena
    Flanagan, Colleen A.
    Millen, Aletta M. E.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (06) : 411 - 422
  • [32] Asthenoazoospermia in patients receiving anti-tumour necrosis factor α agents
    La Montagna, G
    Malesci, D
    Buono, R
    Valentini, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) : 1667 - 1667
  • [33] Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction
    Lula, Jamille Fernandes
    da Costa Rocha, Manoel Otavio
    Pereira Nunes, Maria do Carmo
    Pinho Ribeiro, Antonio Luiz
    Teixeira, Mauro Martins
    Bahia, Maria Terezinha
    Talvani, Andre
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (09) : 825 - 831
  • [34] Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction
    Murtagh, Gillian
    Dawkins, Ian R.
    O'Connell, Ronan
    Badabhagni, Mallikarjuna
    Patel, Anil
    Tallon, Elaine
    O'Hanlon, Rory
    Ledwidge, Mark T.
    McDonald, Kenneth M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (05) : 480 - 486
  • [35] Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction
    Udelson, JE
    Konstam, MA
    JOURNAL OF CARDIAC FAILURE, 2002, 8 (06) : S465 - S471
  • [36] Effects of oral tolvaptan on left ventricular dilatation and function in patients with heart failure and left ventricular systolic dysfunction
    Orlandi, C
    Udelson, J
    Zimmer, C
    Ouyang, J
    Yamamura, Y
    Ozaki, A
    Konstam, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S263 - S263
  • [37] Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents
    Karmiris, Konstantinos
    Bossuyt, Peter
    Sorrentino, Dario
    Moreels, Tom
    Scarcelli, Antonella
    Legido, Jesus
    Dotan, Iris
    Naismith, Graham D.
    Jussila, Airi
    Preiss, Jan C.
    Kruis, Wolfgang
    Li, Andy C. Y.
    Bouguen, Guillaume
    Yanai, Henit
    Steinwurz, Flavio
    Katsanos, Konstantinos H.
    Subramaniam, Kavitha
    Tarabar, Dino
    Zaganas, Ioannis V.
    Ben-Horin, Shomron
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (05): : 382 - 389
  • [38] Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α)
    Nieto Gonzalez, J. C.
    Monteagudo Saez, I.
    Lopez-Longo, F. J.
    Serrano, B.
    Mata Martinez, C.
    Carreno Perez, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 776 - 778
  • [39] Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction
    Davie, AP
    Love, MP
    McMurray, JJV
    BRITISH MEDICAL JOURNAL, 1996, 313 (7052): : 300 - 301
  • [40] Pharmacokinetics of Ibutilide in Patients with Heart Failure Due to Left Ventricular Systolic Dysfunction
    Tisdale, James E.
    Overholser, Brian R.
    Sowinski, Kevin M.
    Wroblewski, Heather A.
    Amankwa, Kwadwo
    Borzak, Steven
    Kingery, Joanna R.
    Coram, Rita
    Zipes, Douglas P.
    Flockhart, David A.
    Kovacs, Richard J.
    PHARMACOTHERAPY, 2008, 28 (12): : 1461 - 1470
12345